Published in Neuroscience on January 28, 2015
Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med (2002) 7.72
Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature (2010) 7.35
Concurrent activation of striatal direct and indirect pathways during action initiation. Nature (2013) 4.87
Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol (2010) 4.77
[The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia]. Wien Klin Wochenschr (1961) 4.63
Preferential activation of midbrain dopamine neurons by appetitive rather than aversive stimuli. Nature (1996) 3.83
Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat Neurosci (1999) 3.45
Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals. Neuron (2004) 3.16
Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell (1995) 2.89
Spontaneous firing patterns and axonal projections of single corticostriatal neurons in the rat medial agranular cortex. J Neurophysiol (1994) 2.87
6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur J Pharmacol (1968) 2.81
Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience (1994) 2.40
Direct and indirect activation of cortical neurons by electrical microstimulation. J Neurophysiol (2006) 2.35
Metabotropic glutamate receptors: from the workbench to the bedside. Neuropharmacology (2010) 2.31
Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J Neurosci (1997) 2.25
Spontaneous subthreshold membrane potential fluctuations and action potential variability of rat corticostriatal and striatal neurons in vivo. J Neurophysiol (1997) 2.23
Visualization of changes in presynaptic function during long-term synaptic plasticity. Nat Neurosci (2001) 2.19
Rapid alterations in corticostriatal ensemble coordination during acute dopamine-dependent motor dysfunction. Neuron (2006) 2.19
L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA. Eur J Neurosci (1998) 2.10
Engineering a memory with LTD and LTP. Nature (2014) 2.03
Cannabinoid receptors and endocannabinoids: evidence for new players. AAPS J (2006) 2.01
A critical time window for dopamine actions on the structural plasticity of dendritic spines. Science (2014) 1.95
Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling. J Pharmacol Exp Ther (2006) 1.93
Endocannabinoid-dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity. Eur J Neurosci (2009) 1.88
Imaging synaptic activity in intact brain and slices with FM1-43 in C. elegans, lamprey, and rat. Neuron (1999) 1.86
Recruitment of N-Type Ca(2+) channels during LTP enhances low release efficacy of hippocampal CA1 perforant path synapses. Neuron (2009) 1.82
Repeated exposure to methamphetamine causes long-lasting presynaptic corticostriatal depression that is renormalized with drug readministration. Neuron (2008) 1.81
The regulation of quantal size. Prog Neurobiol (1991) 1.79
123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors. Eur J Pharmacol (1996) 1.78
Neurodegeneration and neuroprotection in Parkinson disease. NeuroRx (2004) 1.77
The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J Neurosci (1996) 1.70
Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience (1995) 1.68
Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res (1991) 1.67
CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J Neurophysiol (2001) 1.63
Regulation of quantal size by presynaptic mechanisms. Rev Neurosci (2000) 1.60
Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia. Proc Natl Acad Sci U S A (2014) 1.59
Dopamine modulates release from corticostriatal terminals. J Neurosci (2004) 1.54
Levodopa-induced dyskinesias in tyrosine hydroxylase deficiency. Mov Disord (2013) 1.53
Regulation of presynaptic neurotransmission by macroautophagy. Neuron (2012) 1.52
Morphology and synaptic connections of crossed corticostriatal neurons in the rat. J Comp Neurol (1987) 1.52
Does levodopa slow or hasten the rate of progression of Parkinson's disease? J Neurol (2005) 1.52
Ratings of L-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson's disease in rats and mice. Curr Protoc Neurosci (2007) 1.46
Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease. J Neurosci (2009) 1.43
Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors. Life Sci (1997) 1.42
Presynaptic regulation of dopaminergic neurotransmission. J Neurochem (2003) 1.42
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. J Neurosci (2002) 1.40
Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling. Proc Natl Acad Sci U S A (2006) 1.35
Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor. J Neurosci (2000) 1.31
Enhanced sensitivity of caudate neurones to microiontophoretic injections of dopamine in 6-hydroxydopamine treated cats. Brain Res (1972) 1.28
Facilitated glutamatergic transmission in the striatum of D2 dopamine receptor-deficient mice. J Neurophysiol (2001) 1.21
Induction of striatal long-term synaptic depression by moderate frequency activation of cortical afferents in rat. J Physiol (2004) 1.20
Dopamine D2 receptors are present in prefrontal cortical afferents and their targets in patches of the rat caudate-putamen nucleus. J Comp Neurol (2002) 1.20
Priming for l-dopa-induced dyskinesia in Parkinson's disease: a feature inherent to the treatment or the disease? Prog Neurobiol (2008) 1.19
The spectrum of levodopa-induced dyskinesias. Ann Neurol (2000) 1.17
Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids. Eur J Neurosci (2009) 1.16
Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias. Eur J Neurosci (2003) 1.16
A rat brain slice preparation for characterizing both thalamostriatal and corticostriatal afferents. J Neurosci Methods (2006) 1.14
Impulse control disorders in Parkinson's disease: recent advances. Curr Opin Neurol (2011) 1.11
Neuronal vulnerability, pathogenesis, and Parkinson's disease. Mov Disord (2012) 1.11
6-Hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death. Neurodegeneration (1995) 1.11
Labeling of dendritic spines with the carbocyanine dye DiI for confocal microscopic imaging in lightly fixed cortical slices. J Neurosci Methods (2007) 1.08
Glutamate spillover in the striatum depresses dopaminergic transmission by activating group I metabotropic glutamate receptors. J Neurosci (2003) 1.08
Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum. J Neurochem (1997) 1.07
Group I metabotropic glutamate receptors in the monkey striatum: subsynaptic association with glutamatergic and dopaminergic afferents. J Neurosci (2003) 1.07
Nicotinic acetylcholine receptors interact with dopamine in induction of striatal long-term depression. J Neurosci (2002) 1.06
Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum. Neuropharmacology (2001) 1.06
Both A1 and A2a purine receptors regulate striatal acetylcholine release. J Neurochem (1990) 1.05
Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson's disease. Eur J Neurosci (2010) 1.02
Sapap3 deletion anomalously activates short-term endocannabinoid-mediated synaptic plasticity. J Neurosci (2011) 1.02
Impulse control and related disorders in Parkinson's disease. Neurodegener Dis (2012) 0.96
Presynaptic D2 dopaminergic receptors mediate inhibition of excitatory synaptic transmission in rat neostriatum. Brain Res (1995) 0.95
Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids. Neuropharmacology (1991) 0.94
Regulation of prefrontal excitatory neurotransmission by dopamine in the nucleus accumbens core. J Physiol (2012) 0.92
The Corridor Task: a simple test of lateralised response selection sensitive to unilateral dopamine deafferentation and graft-derived dopamine replacement in the striatum. Brain Res Bull (2005) 0.92
Presynaptic long-term depression mediated by Gi/o-coupled receptors. Trends Neurosci (2014) 0.89
Regulation of dendritic calcium release in striatal spiny projection neurons. J Neurophysiol (2013) 0.89
Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models. Neurobiol Dis (2014) 0.88
Benserazide decreases central AADC activity, extracellular dopamine levels and levodopa decarboxylation in striatum of the rat. J Neural Transm (Vienna) (2001) 0.88
Time and dose dependence of the 'priming' of the expression of dopamine receptor supersensitivity. Eur J Pharmacol (1989) 0.85
Acetylcholine encodes long-lasting presynaptic plasticity at glutamatergic synapses in the dorsal striatum after repeated amphetamine exposure. J Neurosci (2013) 0.83
Imaging presynaptic exocytosis in corticostriatal slices. Methods Mol Biol (2011) 0.82
Striatal cell supersensitivity to apomorphine in dopamine-lesioned rats correlated to behaviour. Neuropharmacology (1978) 0.82
Effects of benserazide on L-DOPA-derived extracellular dopamine levels and aromatic L-amino acid decarboxylase activity in the striatum of 6-hydroxydopamine-lesioned rats. Tohoku J Exp Med (2003) 0.82
Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals. J Pharmacol Exp Ther (1988) 0.80
Blockade of NMDA receptors by MK-801 reverses the changes in striatal glutamate immunolabeling in 6-OHDA-lesioned rats. Synapse (2001) 0.78